Trial intelligence / Profile preview

Hormone replacement therapy effects on brain serotonin-1A receptors and mood in postmenopausal women

2007-005685-12Phase 2Completed

Sponsor
Clinical Division of Biological Psychiatry, Medical University of Vienna
Start
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of estradiol valerate and progesterone (3 arms), sponsored by Clinical Division of Biological Psychiatry, Medical University of Vienna. Primary endpoint: Change in cerebral serotonin-1A receptor binding potential. Started Jul 2008; status: completed.

02

Drugs

estradiol valerateprogesterone

Beyond the preview

Go deeper on 2007-005685-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005685-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call